A detailed history of High Tower Advisors, LLC transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 20,200 shares of AKYA stock, worth $48,682. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,200
Previous 27,200 25.74%
Holding current value
$48,682
Previous $63,000 14.29%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.96 - $2.94 $13,720 - $20,580
-7,000 Reduced 25.74%
20,200 $54,000
Q4 2023

Feb 12, 2024

SELL
$3.13 - $5.13 $11,737 - $19,237
-3,750 Reduced 12.12%
27,200 $132,000
Q3 2023

Nov 08, 2023

BUY
$4.24 - $7.44 $84,469 - $148,219
19,922 Added 180.65%
30,950 $143,000
Q2 2023

Aug 14, 2023

BUY
$5.28 - $8.35 $58,227 - $92,083
11,028 New
11,028 $81,000

Others Institutions Holding AKYA

About Akoya Biosciences, Inc.


  • Ticker AKYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 37,892,300
  • Market Cap $91.3M
  • Description
  • Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...
More about AKYA
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.